雷火灸治疗神经根型颈椎病:随机对照试验研究方案
主要结局为Yasuhisa Tanaka 20分评分量表,次要结局包括SF-MPQ-2、NDI和SF-36,评估时间点为基线及治疗第1、2周末。旨在探讨雷火灸是否比布洛芬更有效。
要点
- 主要结局为Yasuhisa Tanaka 20分评分量表。
- 次要结局包括SF-MPQ-2、NDI和SF-36,基线及第1、2周末评估。
核心结论
- 本试验旨在确定雷火灸治疗神经根型颈椎病是否比布洛芬更有效。
关键数值与推荐
- 主要结局指标为Yasuhisa Tanaka 20分评分量表,包含患者自觉症状、医生客观临床评价和社会评价(工作与生活能力)。
- 次要结局指标为SF-MPQ-2、NDI和SF-36,评估时间为基线及治疗第1、2周末。
- 若发生不良事件将予以报告。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Thunder-fire moxibustion originated in China and contains traditional Chinese medicine. It can produce strong firepower, infrared thermal radiation, and medicinal effects when burning on the acupoints. Thunder-fire moxibustion is commonly used in patients with neck pain, but its efficacy has rarely been systematically demonstrated. We designed a randomized trial of thunder-fire moxibustion on cervical spondylotic radiculopathy (CSR) to investigate whether it is more effective than ibuprofen sustained-release capsules. METHODS: One hundred patients will be recruited and randomly divided into thunder-fire moxibustion and ibuprofen groups. The intervention consists of ten treatments and will last for 2 weeks. The Yasuhisa Tanaka 20 Score Scale is used as the primary outcome measure. It contains a combination of the self-conscious symptom in patients, objective clinical evaluation from doctors, and social evaluation (the ability to work and live). The objective and comprehensive evaluation of CSR patients before and after treatment is particularly needed. The Short-Form McGill Pain Questionnaire-2 (SF-MPQ-2), Neck Disability Index score scale (NDI), and the Quality of Life Assessment (SF-36) are applied as secondary outcome measures. The assessment will take place at the baseline and the first and second weekends of treatment. If an adverse event (AEs) occurs, it will be reported. DISCUSSION: The aim of this trial is to determine whether thunder-fire moxibustion is more effective than ibuprofen in the treatment of patients with CSR. TRIAL REGISTRATION: Chinese Clinical Trial Registry (http://www.chictr.org.cn), ChiCTR1800018820. Registered on 11 October 2018.
引用
- Huang Y, Zhang J, Xiong B, et al. Thunder-fire moxibustion for cervical spondylotic radiculopathy: Study protocol for a randomized controlled trial. Trials. 2020. PMID: 32029008. doi:10.1186/s13063-019-4012-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。